Epidermal CCR6 + γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis

Journal of Immunology

Volumn 187, Issue 10, 2011, Pages 5026-5031

  Mabuchi, Tomotaka ^a   Takekoshi, Tomonori ^a   Hwang, Sam T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EPIDERMIS CELL; GAMMA DELTA T LYMPHOCYTE; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; SWELLING;

ANIMALS; DERMATITIS; DISEASE MODELS, ANIMAL; EPIDERMIS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; KERATINOCYTES; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; PSORIASIS; RECEPTORS, CCR6; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 81455141962     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101817     Document Type: Article

References (26)

1. Fitch, E., E. Harper, I. Skorcheva, S. E. Kurtz, and A. Blauvelt. 2007. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr. Rheumatol. Rep. 9: 461-467. (Pubitemid 350305203)
2. Leonardi, C. L., A. B. Kimball, K. A. Papp, N. Yeilding, C. Guzzo, Y. Wang, S. Li, L. T. Dooley, K. B. Gordon; PHOENIX 1 study investigators. 2008. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371: 1665-1674. (Pubitemid 351671883)
3. Nograles, K. E., B. Davidovici, and J. G. Krueger. 2010. New insights in the immunologic basis of psoriasis. Semin. Cutan. Med. Surg. 29: 3-9.
4. Hedrick, M. N., A. S. Lonsdorf, A. K. Shirakawa, C. C. Richard Lee, F. Liao, S. P. Singh, H. H. Zhang, A. Grinberg, P. E. Love, S. T. Hwang, and J. M. Farber. 2009. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J. Clin. Invest. 119: 2317-2329.
5. Zheng, Y., D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651. (Pubitemid 46232884)
6. Nograles, K. E., L. C. Zaba, E. Guttman-Yassky, J. Fuentes-Duculan, M. Suárez- Fariñas, I. Cardinale, A. Khatcherian, J. Gonzalez, K. C. Pierson, T. R. White, et al. 2008. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159: 1092-1102.
7. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
8. Cho, J. S., E. M. Pietras, N. C. Garcia, R. I. Ramos, D. M. Farzam, H. R. Monroe, J. E. Magorien, A. Blauvelt, J. K. Kolls, A. L. Cheung, et al. 2010. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120: 1762-1773.
9. Salgado, C. G., K. Nakamura, M. Sugaya, Y. Tada, A. Asahina, S. Fukuda, Y. Koyama, S. Irie, and K. Tamaki. 1999. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells1. J. Invest. Dermatol. 113: 1021-1027. (Pubitemid 30013347)
10. Szabo, S. K., C. Hammerberg, Y. Yoshida, Z. Bata-Csorgo, and K. D. Cooper. 1998. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. J. Invest. Dermatol. 111: 1072-1078. (Pubitemid 29115177)
11. Lazarova, Z., C. Yee, T. Darling, R. A. Briggaman, and K. B. Yancey. 1996. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J. Clin. Invest. 98: 1509-1518. (Pubitemid 26327858)
12. Girardi, M. 2006. Immunosurveillance and immunoregulation by gammadelta T cells. J. Invest. Dermatol. 126: 25-31.
13. Haas, J. D., F. H. González, S. Schmitz, V. Chennupati, L. Föhse, E. Kremmer, R. Förster, and I. Prinz. 2009. CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-producing gammadelta effector T cells. Eur. J. Immunol. 39: 3488-3497.
14. Singh, S. P., H. H. Zhang, J. F. Foley, M. N. Hedrick, and J. M. Farber. 2008. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 180: 214-221.
15. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646. (Pubitemid 46785128)
16. Grinlinton, F. M., M. A. Skinner, N. M. Birchall, and P. L. Tan. 1993. γ δ + T cells from patients with psoriatic and rheumatoid arthritis respond to streptococcal antigen. J. Rheumatol. 20: 982-987.
17. de Boer, O. J., C. E. Verhagen, A. Visser, J. D. Bos, and P. K. Das. 1994. Cellular interactions and adhesion molecules in psoriatic skin. Acta Derm. Venereol. Suppl. (Stockh.) 186: 15-18. (Pubitemid 24208139)
18. Seung, N. R., E. J. Park, C. W. Kim, K. H. Kim, K. J. Kim, H. J. Cho, and H. R. Park. 2007. Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis. J. Cutan. Pathol. 34: 903-911. (Pubitemid 350132007)
19. Laggner, U., P. Di Meglio, G. K. Perea, C. Hundhausen, K. E. Lacy, N. Ali, C. H. Smith, A. C. Hayday, B. J. Nickoloff, and F. O. Nestle. 2011. Identification of a novel pro-inflammatory human skin-homing Vγ9Vδ2 T cell subset and its role in the pathogenesis of psoriasis. J. Invest. Dermatol. 131: S1.
20. Girardi, M., J. Lewis, E. Glusac, R. B. Filler, L. Geng, A. C. Hayday, and R. E. Tigelaar. 2002. Resident skin-specific γδ T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195: 855-867. (Pubitemid 34286757)
21. Gray, E. E., K. Suzuki, and J. G. Cyster. 2011. Cutting edge: Identification of a motile IL-17-producing γδ T cell population in the dermis. J. Immunol. 186: 6091-6095.
22. Cua, D. J., and C. M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10: 479-489.
23. Roark, C. L., J. D. French, M. A. Taylor, A. M. Bendele, W. K. Born, and R. L. O'Brien. 2007. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing γδ T cells. J. Immunol. 179: 5576-5583.
24. Wohler, J. E., S. S. Smith, K. R. Zinn, D. C. Bullard, and S. R. Barnum. 2009. γδT cells in EAE: early trafficking events and cytokine requirements. Eur. J. Immunol. 39: 1516-1526.
25. Simonian, P. L., F. Wehrmann, C. L. Roark, W. K. Born, R. L. O'Brien, and A. P. Fontenot. 2010. γδ T cells protect against lung fibrosis via IL-22. J. Exp. Med. 207: 2239-2253.
26. Hedrick, M. N., A. S. Lonsdorf, S. T. Hwang, and J. M. Farber. 2010. CCR6 as a possible therapeutic target in psoriasis. Expert Opin. Ther. Targets 14: 911-922.